RELIGARE HEALTH TRUST
68
Note
2015
$’000
2014
$’000
Cash flow from operating activities
Profit before taxes
56,719
56,161
Adjustments for:
Depreciation and amortisation
13,908
12,691
Finance income
(468)
(978)
Finance expenses
6,082
2,545
Minimum Alternate Tax credit written off
–
486
Fair value loss/(gain) on financial derivatives
5,075
(40)
Foreign exchange (gains)/losses
(2,633)
1,780
Fixed assets written off
299
–
Gain from a bargain purchase
16
(401)
–
Foreign currency alignment
282
445
Operating cash flow before working capital changes
78,863
73,090
Changes in working capital:
Increase in trade receivables
(2,396)
(3,146)
Increase in financial assets and other assets
(7,204)
(14,618)
Decrease in inventories
4
2
Increase/(decrease) in trade and other payables and other liabilities
6,656
(1,554)
Cash flows generated from operations
75,923
53,774
Interest received
465
989
Tax paid
(20,452)
(19,348)
Net cash generated from operating activities
55,936
35,415
Cash flow from investing activities
Purchase of property, plant and equipment
15
(8,705)
(4,599)
Investment in short term investments
5,371
8,600
Net cash outflow in a bargain purchase
16
(59,846)
–
Net cash (used in)/generated from investing activities
(63,180)
4,001
Cash flow from financing activities
Interest paid
(3,088)
(1,966)
Distribution paid to unitholders
(52,244)
(43,180)
Net proceeds/(repayments) of borrowings
58,487
(890)
Net cash generated from/(used in) financing activities
3,155
(46,036)
Net decrease in cash and cash equivalents
(4,089)
(6,620)
Cash and cash equivalents at beginning of year
8,259
14,879
Cash and cash equivalents at end of year
23
4,170
8,259
Consolidated Cash Flow Statement
For the financial year ended 31 March 2015
The accompanying accounting policies and explanatory notes form an integral part of the financial statements.
